4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-25-058580
Director acquired 14,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2025-06-09 | Option exercise | +1,600 | $7.80 | $12,480 | 3,447,413 | I |
| Fairmount Funds Management LLC Director | 2025-06-10 | Option exercise | +12,500 | $12.31 | $153,875 | 3,459,913 | I |
| Derivatives | |||||||
| Fairmount Funds Management LLC Director | 2025-06-09 | Option exercise · Stock Option (Right to Buy) | −1,600 | 0 | I | ||
| Fairmount Funds Management LLC Director | 2025-06-10 | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | I | ||
Loading xslF345X05/tm2517665d1_4seq1.xml…